To date, no vinca alkaloids have been shown to be of clinical utility. Intravenous Navelbine has demonstrated activity in non-small cell lung cancer, breast cancer, Hodgkins Disease and ovarian cancer. This study is designed to determine the bioavailability of this agent.
Showing the most recent 10 out of 65 publications